江 振源

研究成果

每年研究成果 1996 2020

• 3652 引文
• 30 h-指數
• 131 文章
• 6 快報
• 3 社論
• 3 回顧型文獻
• 2 更多
  • 1 章節
  • 1 評論/辯論

每年研究成果

每年研究成果

搜尋結果

• 2020

  Genetic mutations associated with isoniazid resistance in mycobacterium tuberculosis in Mongolia

  Narmandakh, E., Tumenbayar, O., Borolzoi, T., Erkhembayar, B., Boldoo, T., Dambaa, N., Burneebaatar, B., Nymadawa, N., Mitarai, S., Jav, S. & Chiang, C. Y., 七月 2020, 於: Antimicrobial Agents and Chemotherapy. 64, 7, e00537-20.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Mongolia
  • Isoniazid
  • Mycobacterium tuberculosis
  • Mutation
  • Rifampin

• Green Light Committee and WHO recommendations

  Chiang, C. Y., 八月 1 2020, 於: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 24, 8, p. 873-874 2 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  1 引文 斯高帕斯（Scopus）

• Investigation of the efficacy of the short regimen for rifampicin-resistant TB from the STREAM trial

  Phillips, P. P. J., Van Deun, A., Ahmed, S., Goodall, R. L., Meredith, S. K., Conradie, F., Chiang, C. Y., Rusen, I. D. & Nunn, A. J., 十二月 1 2020, 於: BMC Medicine. 18, 1, 314.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Rifampin
  • Recurrence
  • Intention to Treat Analysis
  • Pharmaceutical Preparations
  • Tuberculosis

• New diseases and old threats: Lessons from tuberculosis for the COVID-19 response

  Dara, M., Sotgiu, G., Reichler, Chiang, C. Y., Chee, C. B. E. & Migliori, G. B., 五月 1 2020, 於: International Journal of Tuberculosis and Lung Disease. 24, 5, p. 544-545 2 p.

  研究成果: 雜誌貢獻 › 快報 › 同行評審
  25 引文 斯高帕斯（Scopus）

• Progress in the roll-out of multidrug-resistant tuberculosis (MDR-TB) treatments

  Heng, M., Allmendinger, S., Chiang, C. Y., Trébucq, A. & Horsburgh, C. R., 五月 1 2020, 於: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 24, 5, p. 535-536 2 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

• Tackling the threat of COVID-19 in Africa: An urgent need for practical planning

  Chiang, C. Y. & Sony, A. E., 五月 1 2020, 於: International Journal of Tuberculosis and Lung Disease. 24, 5, p. 541-542 2 p.

  研究成果: 雜誌貢獻 › 快報 › 同行評審
  10 引文 斯高帕斯（Scopus）

• The looming threat of bedaquiline resistance in tuberculosis

  Chiang, C. Y., Chiang, C. Y., Chiang, C. Y., Trébucq, A., Piubello, A., Rieder, H. L., Rieder, H. L., Schwoebel, V., Van Deun, A. & Van Deun, A., 六月 1 2020, 於: European Respiratory Journal. 55, 6, 2000718.

  研究成果: 雜誌貢獻 › 快報 › 同行評審

  開啟存取
  1 引文 斯高帕斯（Scopus）

• World Health Organization 2018 treatment guidelines for rifampicin-resistant tuberculosis: uncertainty, potential risks and the way forward

  Van Deun, A., Decroo, T., Tahseen, S., Trébucq, A., Schwoebel, V., Ortuno-Gutierrez, N., de Jong, B. C., Rieder, H. L., Piubello, A. & Chiang, C. Y., 一月 2020, 於: International Journal of Antimicrobial Agents. 55, 1, 105822.

  研究成果: 雜誌貢獻 › 社論 › 同行評審

  開啟存取

  • bedaquiline
  • Rifampin
  • Linezolid
  • Uncertainty
  • Fluoroquinolones
  4 引文 斯高帕斯（Scopus）
• 2019

  A trial of a shorter regimen for rifampin-resistant tuberculosis

  Nunn, A. J., Phillips, P. P. J., Meredith, S. K., Chiang, C. Y., Conradie, F., Dalai, D., Van Deun, A., Dat, P. T. O., Lan, N., Master, I., Mebrahtu, T., Meressa, D., Moodliar, R., Ngubane, N., Sanders, K., Squire, S. B., Torrea, G., Tsogt, B. & Rusen, I. D., 三月 28 2019, 於: New England Journal of Medicine. 380, 13, p. 1201-1213 13 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Fluoroquinolones
  • Aminoglycosides
  • Rifampin
  • Tuberculosis
  • United States Agency for International Development
  94 引文 斯高帕斯（Scopus）

• Calling time on asthma deaths in tropical regions—how much longer must people wait for essential medicines?

  Asher, I., Bissell, K., Chiang, C. Y., El Sony, A., Ellwood, P., García-Marcos, L., Marks, G. B., Mortimer, K., Pearce, N. & Strachan, D., 一月 1 2019, 於: The Lancet Respiratory Medicine. 7, 1, p. 13-15 3 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
  6 引文 斯高帕斯（Scopus）

• Challenges and opportunities to prevent tuberculosis in people living with HIV in low-income countries

  Harries, A. D., Schwoebel, V., Monedero-Recuero, I., Aung, T. K., Chadha, S., Chiang, C-Y., Conradie, F., Dongo, J-P., Heldal, E., Jensen, P., Nyengele, J. P. K., Koura, K. G., Kumar, A. M. V., Lin, Y., Mlilo, N., Nakanwagi-Mukwaya, A., Ncube, R. T., Nyinoburyo, R., Oo, N. L., Patel, L. N. 及其他17, Piubello, A., Rusen, I. D., Sanda, T., Satyanarayana, S., Syed, I., Thu, A. S., Tonsing, J., Trébucq, A., Zamora, V., Zishiri, C., Hinderaker, S. G., Aït-Khaled, N., Roggi, A., Caminero Luna, J., Graham, S. M., Dlodlo, R. A. & Fujiwara, P. I., 二月 1 2019, 於: International Journal of Tuberculosis and Lung Disease. 23, 2, p. 241-251 11 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Income
  • Tuberculosis
  • HIV
  • Isoniazid
  • Therapeutics
  7 引文 斯高帕斯（Scopus）

• Essential medicines at the national level: The global asthma network’s essential asthma medicines survey 2014

  Global Asthma Network Study Group, Bissell, K., Ellwood, P., Ellwood, E., Chiang, C. Y., Marks, G. B., El Sony, A., Asher, I., Billo, N. & Perrin, C., 二月 1 2019, 於: International Journal of Environmental Research and Public Health. 16, 4, 605.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Income
  • Asthma
  • Adrenal Cortex Hormones
  • Noncommunicable Diseases
  • Albuterol
  4 引文 斯高帕斯（Scopus）

• Impact of universal drug susceptibility testing and effective management of multidrug-resistant tuberculosis in Taiwan

  Lee, P. H., Chan, P. C., Peng, Y. T., Chu, P. W., Wu, M. H., Jou, R., Yu, M. C., Lin, C. J., Huang, Y. W., Chien, S. T., Lee, J. J. & Chiang, C. Y., 四月 1 2019, 於: PLoS One. 14, 4, e0214792.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Multidrug-Resistant Tuberculosis
  • tuberculosis
  • Taiwan
  • drugs
  • Testing
  3 引文 斯高帕斯（Scopus）

• Multidrug-resistant tuberculosis

  Chiang, C. Y., Van Deun, A., Trébucq, A., Piubello, A., Schwoebel, V. & Rieder, H. L., 七月 27 2019, 於: The Lancet. 394, 10195, 1 p.

  研究成果: 雜誌貢獻 › 快報 › 同行評審

  開啟存取
  4 引文 斯高帕斯（Scopus）

• Outcome definitions for multidrug-resistant tuberculosis treated with shorter treatment regimens

  Schwoebel, V., Chiang, C. Y., Trébucq, A., Piubello, A., Aït-Khaled, N., Koura, K. G., Heldal, E., Van Deun, A. & Rieder, H. L., 一月 1 2019, 於: International Journal of Tuberculosis and Lung Disease. 23, 5, p. 619-624 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Multidrug-Resistant Tuberculosis
  • Income
  • Therapeutics
  • Sputum
  • Treatment Failure
  4 引文 斯高帕斯（Scopus）

• Progress in global rollout of new multidrug-resistant tuberculosis treatments

  Held, K., McAnaw, S., Chiang, C. Y., Trebucq, A. & Horsburgh, C. R., 九月 1 2019, 於: International Journal of Tuberculosis and Lung Disease. 23, 9, p. 996-999 4 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Multidrug-Resistant Tuberculosis
  • OPC-67683
  • bedaquiline
  • Internet
  • Lung Diseases
  1 引文 斯高帕斯（Scopus）

• Short-Course Regimen for Multidrug-Resistant Tuberculosis: A Decade of Evidence

  Trébucq, A., Decroo, T., Van Deun, A., Piubello, A., Chiang, C-Y., Koura, K. G. & Schwoebel, V., 十二月 25 2019, 於: Journal of Clinical Medicine. 9, 1

  研究成果: 雜誌貢獻 › 回顧型文獻 › 同行評審

  • Multidrug-Resistant Tuberculosis
  • Fluoroquinolones
  • Gatifloxacin
  • Moxifloxacin
  • Levofloxacin

• Tolerability of rifapentine-based regimens in latent tuberculosis infection treatment in the elderly

  Chan, P. C., Lee, P. H., Lu, M. J., Huang, Y. C., Feng, T. Y., Chen, W. W., Lee, C. C., Huang, Y. F. & Chiang, C. Y., 三月 1 2019, 於: The European respiratory journal. 53, 3

  研究成果: 雜誌貢獻 › 快報 › 同行評審

  開啟存取
  2 引文 斯高帕斯（Scopus）

• Treatment outcomes for multidrug-resistant tuberculosis in Eastern Taiwan

  Lin, C. B., Sun, H. C., Chiang, C. Y., Wu, C. W., Chou, H. W., Tang, T. Q. & Lee, J. J., 一月 1 2019, 於: Tzu Chi Medical Journal. 31, 1, p. 35-39 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Multidrug-Resistant Tuberculosis
  • Taiwan
  • Pulmonologists
  • Lost to Follow-Up
  • Pulmonary Tuberculosis
  3 引文 斯高帕斯（Scopus）
• 2018

  Building the evidence base for shortened MDR-TB treatment regimens

  Rusen, I. D. & Chiang, C. Y., 一月 1 2018, 於: International Journal of Tuberculosis and Lung Disease. 22, 1, 1 p.

  研究成果: 雜誌貢獻 › 社論 › 同行評審
  3 引文 斯高帕斯（Scopus）

• Metformin use is associated with a low risk of tuberculosis among newly diagnosed diabetes mellitus patients with normal renal function: A nationwide cohort study with validated diagnostic criteria

  Lee, M-C., Chiang, C-Y., Lee, C-H., Ho, C-M., Chang, C-H., Wang, J-Y. & Chen, S-M., 十月 1 2018, 於: PLoS One. 13, 10, e0205807.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • metformin
  • cohort studies
  • diabetes mellitus
  • renal function
  • tuberculosis
  17 引文 斯高帕斯（Scopus）

• QTc and anti-tuberculosis drugs: A perfect storm or a tempest in a teacup? Review of evidence and a risk assessment

  Monedero-Recuero, I., Hernando-Marrupe, L., Sánchez-Montalvá, A., Cox, V., Tommasi, M., Furin, J., Chiang, C. Y., Quelapio, M., Koura, K. G., Trébucq, A., Padanilam, X., Dravniece, G. & Piubello, A., 十二月 1 2018, 於: International Journal of Tuberculosis and Lung Disease. 22, 12, p. 1411-1421 11 p.

  研究成果: 雜誌貢獻 › 回顧型文獻 › 同行評審

  • Risk Assessment
  • Tuberculosis
  • Extensively Drug-Resistant Tuberculosis
  • Torsades de Pointes
  • Pharmaceutical Preparations
  8 引文 斯高帕斯（Scopus）

• Should gatifloxacin be included in the model list of essential medicines?

  Chiang, C-Y., Trébucq, A., Piubello, A., Rieder, H. L. & Van Deun, A., 二月 2018, 於: European Respiratory Journal. 51, 2

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  4 引文 斯高帕斯（Scopus）

• Should tobacco control intervention be implemented into tuberculosis control program?

  Chiang, C. Y. & Bam, T. S., 七月 3 2018, 於: Expert Review of Respiratory Medicine. 12, 7, p. 541-543 3 p.

  研究成果: 雜誌貢獻 › 社論 › 同行評審
  3 引文 斯高帕斯（Scopus）

• Treatment outcomes of multidrug-resistant tuberculosis in Taiwan: Tackling loss to follow-up

  Yu, M. C., Chiang, C. Y., Lee, J. J., Chien, S. T., Lin, C. J., Lee, S. W., Lin, C. B., Yang, W. T., Wu, Y. H. & Huang, Y. W., 七月 2 2018, 於: Clinical Infectious Diseases. 67, 2, p. 202-210 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Multidrug-Resistant Tuberculosis
  • Taiwan
  • Odds Ratio
  • Confidence Intervals
  • Treatment Failure
  10 引文 斯高帕斯（Scopus）

• Tuberculosis re-treatment after exclusion of rifampicin resistance

  Chiang, C-Y. & Trébucq, A., 二月 2018, 於: European Respiratory Journal. 51, 2

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  2 引文 斯高帕斯（Scopus）
• 2017

  Global Asthma Network survey suggests more national asthma strategies could reduce burden of asthma

  Global Asthma Network Study Group, 三月 1 2017, 於: Allergologia et Immunopathologia. 45, 2, p. 105-114 10 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Asthma
  • Research Personnel
  • Child
  • Age Groups
  13 引文 斯高帕斯（Scopus）

• Group 5 drugs for multidrug-resistant tuberculosis: Individual patient data meta-analysis

  Fox, G. J., Benedetti, A., Cox, H., Koh, W. J., Viiklepp, P., Ahuja, S., Pasvol, G., Menzies, D., Ahuja, S., Ashkin, D., Avendaño, M., Banerjee, R., Bauer, M., Hollm-Delgado, M. G., Pai, M., Shah, L., Bayona, J. N., Becerra, M., Burgos, M., Centis, R. 及其他53, D'Ambrosio, L., Migliori, G. B., Chan, E. D., Chiang, C. Y., De Lange, W. C. M., Van Altena, R., Van Der Werf, T. S., De Riemer, K., Dung, N. H., Enarson, D., Falzon, D., Granich, R. M., Flanagan, K., Flood, J., Gandhi, N., Garcia-Garcia, L., Holtz, T. H., Iseman, M., Strand, M. J., Jarlsberg, L. G., Royce, S., Keshavjee, S., Kim, H. R., Mitnick, C. D., Lancaster, J., Van Der Walt, M., Lange, C., Leimane, V., Riekstina, V., Leung, C. C., Li, J., Narita, M., O'Riordan, P., Palmero, D., Park, S. K., Pena, J., Pérez-Guzmán, C., Ponce-De-Leon, A., Sifuentes-Osornio, J., Quelapio, M. I. D., Tupasi, T. E., Robert, J., Schaaf, H. S., Seung, K. J., Shin, S. S., Shim, T. S., Shiraishi, Y., Sotgiu, G., Tabarsi, P., Vargas, M. H., Westenhouse, J., Yew, W. W. & Yim, J. J., 一月 1 2017, 於: European Respiratory Journal. 49, 1, 1600993.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Multidrug-Resistant Tuberculosis
  • Meta-Analysis
  • Data Analysis
  • Thioacetazone
  • Clofazimine
  15 引文 斯高帕斯（Scopus）

• Latent infection with Mycobacterium tuberculosis

  Chiang, C. Y., Hinderaker, S. G., Lin, H. H. & Enarson, D. A., 一月 1 2017, Handbook of Global Tuberculosis Control: Practices and Challenges. Springer US, p. 359-368 10 p.

  研究成果: 書貢獻/報告類型 › 章節

• Osthole treatment ameliorates Th2-mediated allergic asthma and exerts immunomodulatory effects on dendritic cell maturation and function

  Chiang, C. Y., Lee, C. C., Fan, C. K., Huang, H. M., Chiang, B. L. & Lee, Y. L., 十一月 1 2017, 於: Cellular and Molecular Immunology. 14, 11, p. 935-947 13 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • osthol
  • Dendritic Cells
  • Asthma
  • Regulatory T-Lymphocytes
  • Interleukin-10
  18 引文 斯高帕斯（Scopus）

• Prescription practice of anti-tuberculosis drugs in Yunnan, China: A clinical audit

  Xu, L., Chen, J., Innes, A. L., Li, L. & Chiang, C. Y., 十月 1 2017, 於: PLoS One. 12, 10, e0187076.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Clinical Audit
  • audits
  • tuberculosis
  • Prescriptions
  • China
  1 引文 斯高帕斯（Scopus）

• Shortened multidrug-resistant tuberculosis regimens overcome low-level fluoroquinolone resistance

  Van Deun, A. & Chiang, C. Y., 六月 1 2017, 於: European Respiratory Journal. 49, 6, 1700223.

  研究成果: 雜誌貢獻 › 快報 › 同行評審
  14 引文 斯高帕斯（Scopus）

• Shorter regimens for multidrug-resistant tuberculosis should also be applicable in Europe

  Heldal, E., Van Deun, A., Chiang, C-Y. & Rieder, H. L., 六月 2017, 於: European Respiratory Journal. 49, 6

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  4 引文 斯高帕斯（Scopus）

• The Global Asthma Network rationale and methods for Phase I global surveillance: prevalence, severity, management and risk factors

  Ellwood, P., Asher, M. I., Billo, N. E., Bissell, K., Chiang, C. Y., Ellwood, E. M., El-Sony, A., García-Marcos, L., Mallol, J., Marks, G. B., Pearce, N. E. & Strachan, D. P., 一月 1 2017, 於: European Respiratory Journal. 49, 1, 1601605.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Asthma
  • Hypersensitivity
  • Rhinitis
  • Eczema
  • Child
  42 引文 斯高帕斯（Scopus）
• 2016

  Ambient air pollution and risk of tuberculosis: A cohort study

  Lai, T. C., Chiang, C. Y., Wu, C. F., Yang, S. L., Liu, D. P., Chan, C. C. & Lin, H. H., 一月 1 2016, 於: Occupational and Environmental Medicine. 73, 1, p. 56-61 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Air Pollution
  • Tuberculosis
  • Cohort Studies
  • Nitrogen Oxides
  • Traffic-Related Pollution
  44 引文 斯高帕斯（Scopus）

• Does enhanced diabetes management reduce the risk and improve the outcome of tuberculosis?

  Lo, H. Y., Yang, S. L., Lin, H. H., Bai, K. J., Lee, J. J., Lee, T. I. & Chiang, C. Y., 三月 1 2016, 於: International Journal of Tuberculosis and Lung Disease. 20, 3, p. 376-382 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Risk Management
  • Tuberculosis
  • Diabetes Mellitus
  • National Health Programs
  • Incentive Reimbursement
  15 引文 斯高帕斯（Scopus）

• Gatifloxacin for short, effective treatment of multidrug-resistant tuberculosis

  Chiang, C. Y., Van Deun, A. & Rieder, H. L., 九月 1 2016, 於: International Journal of Tuberculosis and Lung Disease. 20, 9

  研究成果: 雜誌貢獻 › 回顧型文獻 › 同行評審

  • Gatifloxacin
  • Multidrug-Resistant Tuberculosis
  • Niger
  • Bangladesh
  • Cameroon
  20 引文 斯高帕斯（Scopus）

• Glycemic Control and the Risk of Tuberculosis: A Cohort Study

  Lee, P. H., Fu, H., Lai, T. C., Chiang, C. Y., Chan, C. C. & Lin, H. H., 八月 2016, 於: PLoS Medicine. 13, 8, e1002072.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Tuberculosis
  • Cohort Studies
  • Hazards
  • Plasmas
  • Glucose
  41 引文 斯高帕斯（Scopus）

• Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method

  Mitnick, C. D., White, R. A., Lu, C., Rodriguez, C. A., Bayona, J., Becerra, M. C., Burgos, M., Centis, R., Cohen, T., Cox, H., D'Ambrosio, L., Danilovitz, M., Falzon, D., Gelmanova, I. Y., Gler, M. T., Grinsdale, J. A., Holtz, T. H., Keshavjee, S., Leimane, V., Menzies, D. 及其他68, Migliori, G. B., Milstein, M. B., Mishustin, S. P., Pagano, M., Quelapio, M. I., Shean, K., Shin, S. S., Tolman, A. W., Van Der Walt, M. L., Van Deun, A., Viiklepp, P., Ahuja, S. D., Andreev, Y. G., Ashkin, D., Avendano, M., Banerjee, R., Bauer, M., Benedetti, A., Brand, J., Chan, E. D., Chiang, C. Y., DeRiemer, K., Dung, N. H., Enarson, D., Flanagan, K., Flood, J., García-García, L., Gandhi, N., Granich, R. M., Hollm-Delgado, M. G., Iseman, M. D., Jarlsberg, L. G., Kim, H. R., Koh, W. J., Lancaster, J., Lange, C., De Lange, W. C. M., Leung, C. C., Li, J., Maug, A. K. J., Narita, M., Odendaal, R., O'Riordan, P., Pai, M., Palmero, D., Seung-Kyu, Pasvol, G., Peña, J., Pérez-Guzmán, C., Ponce-De-Leon, A., Riekstina, V., Robert, J., Royce, S., Schaaf, H. S., Seung, K. J., Shah, L., Shim, T. S., Shiraishi, Y., Sifuentes-Osornio, J., Strand, M. J., Shaheed, P. T., Tupasi, T. E., Van Altena, R., Van Der Werf, T. S., Vargas, M. H., Westenhouse, J., Yew, W. W. & Yim, J. J., 十月 1 2016, 於: European Respiratory Journal. 48, 4, p. 1160-1170 11 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Multidrug-Resistant Tuberculosis
  • Treatment Failure
  • Frailty
  • Sputum
  • Microscopy
  17 引文 斯高帕斯（Scopus）

• Propensity score-based approaches to confounding by indication in individual patient data meta-analysis: Non-standardized treatment for multidrug resistant tuberculosis

  Fox, G. J., Benedetti, A., Mitnick, C. D., Pai, M., Menzies, D., Ahuja, S., Ashkin, D., Avendaño, M., Banerjee, R., Bauer, M., Becerra, M., Burgos, M., Centis, R., Chan, E. D., Chiang, C. Y., Cobelens, F., Cox, H., D'Ambrosio, L., De Lange, W. C. M., DeRiemer, K. 及其他60, Enarson, D., Falzon, D., Flanagan, K., Flood, J., Gandhi, N., Garcia-Garcia, L., Granich, R. M., Hollm-Delgado, M. G., Holtz, T. H., Hopewell, P., Iseman, M., Jarlsberg, L. G., Keshavjee, S., Kim, H. R., Lancaster, J., Lange, C., Leimane, V., Leung, C. C., Koh, W. J., Li, J., Menzies, D., Migliori, G. B., Narita, M., Nathanson, E., Odendaal, R., O'Riordan, P., Pai, M., Palmero, D., Park, S. K., Pasvol, G., Pena, J., Pérez-Guzmán, C., Ponce-de-Leon, A., Quelapio, M. I. D., Quy, H. T., Riekstina, V., Robert, J., Royce, S., Salim, M., Schaaf, H. S., Seung, K. J., Shah, L., Shean, K., Shim, T. S., Shin, S. S., Shiraishi, Y., Sifuentes-Osornio, J., Sotgiu, G., Strand, M. J., Sung, S. W., Tabarsi, P., Tupasi, T. E., Vargas, M. H., Van Altena, R., Viiklepp, P., Van Der Walt, M., Van Der Werf, T. S., Westenhouse, J., Yew, W. W. & Yim, J. J., 三月 1 2016, 於: PLoS One. 11, 3, e0151724.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Multidrug-Resistant Tuberculosis
  • meta-analysis
  • tuberculosis
  • Fluoroquinolones
  • Propensity Score
  6 引文 斯高帕斯（Scopus）

• Surgery as an adjunctive treatment for multidrug-resistant tuberculosis: An individual patient data metaanalysis

  Fox, G. J., Mitnick, C. D., Benedetti, A., Chan, E. D., Becerra, M., Chiang, C. Y., Keshavjee, S., Koh, W. J., Shiraishi, Y., Viiklepp, P., Yim, J. J., Pasvol, G., Robert, J., Shim, T. S., Shin, S. S. & Menzies, D., 四月 1 2016, 於: Clinical Infectious Diseases. 62, 7, p. 887-895 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Multidrug-Resistant Tuberculosis
  • Pneumonectomy
  • Lung
  • Odds Ratio
  • Confidence Intervals
  38 引文 斯高帕斯（Scopus）

• The influence of smoking on pulmonary tuberculosis in diabetic and non-diabetic patients

  Bai, K. J., Lee, J. J., Chien, S. T., Suk, C. W. & Chiang, C. Y., 六月 1 2016, 於: PLoS One. 11, 6, e0156677.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • tuberculosis
  • Pulmonary Tuberculosis
  • lungs
  • Smoking
  • Medical problems
  6 引文 斯高帕斯（Scopus）
• 2015

  Are pulmonary non-tuberculous mycobacteria of concern in the Western Pacific Region?

  Yew, W. W., Chiang, C. Y., Lumb, R. & Islam, T., 五月 1 2015, 於: International Journal of Tuberculosis and Lung Disease. 19, 5, p. 499-500 2 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  1 引文 斯高帕斯（Scopus）

• A smoking cessation intervention among tuberculosis patients in rural China

  Lin, Y., Wang, L-X., Qiu, L-X., Huang, Q., Shu, Q., Lin, H-X., Meng, X., Zeng, X-L., Xiao, L-X., Bam, T. S. & Chiang, C-Y., 九月 21 2015, 於: Public Health Action. 5, 3, p. 183-7 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Smoking Cessation
  • China
  • Tuberculosis
  • Smokers
  • Smoking

• Assessment of a revolving drug fund for essential asthma medicines in Benin

  Agodokpessi, G., Aït-Khaled, N., Gninafon, M., Tawo, L., Bekou, W., Perrin, C., Bissell, K., Billo, N., Enarson, D. A. & Chiang, C. Y., 2015, 於: Journal of Pharmaceutical Policy and Practice. 8, 1, p. 1-8 8 p., 12.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Essential Drugs
  • Benin
  • Financial Management
  • Asthma
  • Pharmaceutical Preparations
  2 引文 斯高帕斯（Scopus）

• Health system delay among patients with tuberculosis in Taiwan: 2003-2010

  Chen, C. C., Chiang, C. Y., Pan, S. C., Wang, J. Y. & Lin, H. H., 十一月 2 2015, 於: BMC Infectious Diseases. 15, 1, 491.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Taiwan
  • Tuberculosis
  • Health
  • Delivery of Health Care
  • National Health Programs
  15 引文 斯高帕斯（Scopus）

• Management of asthma in resource-limited settings: Role of low-cost corticosteroid/β-agonist combination inhaler

  Chiang, C. Y., Aït-Khaled, N., Bissell, K. & Enarson, D. A., 二月 1 2015, 於: International Journal of Tuberculosis and Lung Disease. 19, 2, p. 129-136 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Nebulizers and Vaporizers
  • Adrenal Cortex Hormones
  • Asthma
  • Costs and Cost Analysis
  • 3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole
  3 引文 斯高帕斯（Scopus）

• Patient delay in the diagnosis and treatment of tuberculosis in China: findings of case detection projects

  Lin, Y., Enarson, DA., Chiang, C-Y., Rusen, ID., Qiu, LX., Kan, XH., Yuan, YL., Du, J., Zhang, TH., Li, Y., Li, XF., Du, CT. & Zhang, LX., 三月 21 2015, 於: Public Health Action. 5, 1, p. 65-9 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • China
  • Tuberculosis
  • Health Services
  • Pulmonary Tuberculosis
  • Gross Domestic Product

• Smoking cessation and smokefree environments for tuberculosis patients in Indonesia-a cohort study

  Bam, T. S., Aditama, T. Y., Chiang, C. Y., Rubaeah, R. & Suhaemi, A., 七月 2 2015, 於: BMC Public Health. 15, 1, 604.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Indonesia
  • Smoking Cessation
  • Tuberculosis
  • Cohort Studies
  • Smokers
  9 引文 斯高帕斯（Scopus）

• Surveillance of tuberculosis in Taipei: The influence of nontuberculous mycobacteria

  Chiang, C. Y., Yu, M. C., Yang, S. L., Yen, M. Y. & Bai, K. J., 十一月 6 2015, 於: PLoS One. 10, 11, e0142324.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Nontuberculous Mycobacteria
  • Public health
  • tuberculosis
  • Mycobacterium
  • Tuberculosis
  4 引文 斯高帕斯（Scopus）